Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Conteh, Lesong ^a,b   Patouillard, Edith ^a   Kweku, Margaret ^a,c   Legood, Rosa ^a   Greenwood, Brian ^a   Chandramohan, Daniel ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GHANA   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; FANSIDAR; PLACEBO; AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ARTICLE; CHILD; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG INTERMITTENT THERAPY; GHANA; HEALTH CARE COST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; SENSITIVITY ANALYSIS; STAFF TRAINING; ANEMIA; DRUG COMBINATION; ECONOMICS; METHODOLOGY; PREVENTIVE HEALTH SERVICE; SEASON;

ARTESUNATE;

AMODIAQUINE; ANEMIA; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DRUG COMBINATIONS; GHANA; HUMANS; INFANT; MALARIA; PREVENTIVE HEALTH SERVICES; PYRIMETHAMINE; SEASONS; SULFADOXINE;

EID: 77957881268     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012223     Document Type: Article

References (53)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434(7030): 214-7.
2. WHO (2000) Expert Committee on Malaria Twentieth Report. Geneva, WHO Report No: Technical Report Series, No. 892.
3. Asenso-Okyere WK, Dzator JA (1997) Household cost of seeking malaria care. A retrospective study of two districts in Ghana. Social Science & Medicine 45(5): 659-67.
4. Deressa W, Hailemariam D, Ali A (2007) Economic costs of epidemic malaria to households in rural Ethiopia. Trop Med Int Health 12(10): 1148-56.
5. Wiseman V, McElroy B, Conteh L, Stevens W (2006) Malaria prevention in The Gambia: patterns of expenditure and determinants of demand at the household level. Tropical Medicine and International Health 11(4): 419-31.
6. Owusu-Agyei S, Awini E, Anto F, Mensah-Afful T, Adjuik M, et al. (2007) Assessing malaria control in the Kassena-Nankana district of northern Ghana through repeated surveys using the RBM tools. Malaria Journal 6: 103.
7. Kiszewski A, Johns B, Schapira A, Delacollette C, Crowell V, et al. (2007) Estimated global resources needed to attain international malaria control goals. Bull World Health Organ 85(8): 623-30.
8. Sachs J (2001) Macroeconomics and Health: Investing in Health for Economic Development. Geneva: World Health Organisation.
9. Ankomah Asante F, Asenso-Okyere WK (2003) Economic Burden of Malaria in Ghana. Institute of Statistical, Social and Economic Research (ISSER): University of Ghana. http://www.who.int/countries/gha/publications/Economic_Burden_of_Malaria_in_Ghana_Final_Report_Nov03.pdf.
10. Cisse B, Sokhna C, Boulanger D, Milet J, Ba EH, et al. (2006) Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebocontrolled, double-blind trial. The Lancet 367(9511): 659-67.
11. Dicko A, Sagara S, Sissoko MS, Guindo O, Diallo ABI, et al. (2004) Impact of intermittent preventive treatment with sulfadoxine pyrimethamine targetting the transmission season on the incidence of clinical malaria in children of 6 months to 10 years in Kambila, Mali. American Journal Tropical Medicine and Hygiene 71: 1-79.
12. Sokhna C, Cissé B, Bâ E, Milligan P, Hallett R, et al. (2008) A Trial of the Efficacy, Safety and Impact on Drug Resistance of Four Drug Regimens for Seasonal Intermittent Preventive Treatment for Malaria in Senegalese Children. PLoS ONE 3(1): e1471.
13. Cisse B, Cairns M, Faye E, Ndiaye O, Faye B, et al. (2009) Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children. PLoS ONE 4(9): e7164.
14. Kweku M, Liu D, Adjuik M, Binka F, Seidu M, et al. (2008) Seasonal Intermittent Preventive Treatment for the Prevention of Anaemia and Malaria in Ghanaian Children: A Randomized, Placebo Controlled Trial. PLoS ONE 3(12): e4000.
15. Johns B, Baltussen R, Hutubessy R (2003) Programme costs in the economic evaluation of health interventions. Cost Effectiveness and Resource Allocation; 1(1): 1.
16. Creese A, Parker D (1994) Cost analysis of primary health care: a training manual for programme managers Geneva: World Health Organisation.
17. Phillips M, Mills A, Dye C (1993) Guidelines for Cost-Effectiveness Analysis of Vector Control. Geneva: World Health Organisation.
18. OANDA Historic Currency Converter Website (2010) http://www.oanda.com/convert/fxhistory.
19. Budlender D (2002) Why should we care about unpaid work? A guidebook prepared for the Unitd Nations Development Fund for Women. HarareZambia: Southern African Region Office.
20. International Monetary Fund. Data Mapper Website (2009) http://www.imf.org/external/datamapper/index.php].
21. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ (1985) Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making. Summer; 5(2): 157-77.
22. Fenwick E, Marshall D, Levy A, Nichol G (2006) Using and interpreting costeffectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Services Research 6(52).
23. Ghanaian Ministry of Health (2007) Hohoe District Medical Health Annual Report.
24. Kolaczinski J, Hanson K (2006) Costing the distribution of insecticide-treated nets: a review of cost and cost-effectiveness studies to provide guidance on standardization of costing methodology. 5: 37.
25. Conteh L, Sharp BL, Streat E, Barreto A, Konar S (2004) The cost and costeffectiveness of malaria vector control by residual insecticide house-spraying in southern Mozambique: a rural and urban analysis. Trop Med Int Health 9(1): 125-32.
26. Manzi F, Hutton G, Schellenberg J, Tanner M, Alsono P, et al. (2008) From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control. BMC Health Services Research 8(165).
27. Temperley M, Mueller D, Njagi JK, Akhwale W, Clarke S, et al. (2008) Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya. Malaria Journal 7: 196.
28. Mbonye AK, Hansen KS, Bygbjerg IC, Magnussen P (2008) Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene 102(7): 685-93.
29. Mueller D, Wiseman V, Bakusa D, Morgah K, Dare A (2008) Cost-effectiveness analysis of insecticide-treated net distribution as part of the Togo Integrated Child Health Campaign. Malaria Journal 7(1): 73.
30. Yukich J, Lengeler C, Tediosi F, Brown N, Mulligan J-A, et al. (2008) Costs and consequences of large-scale vector control for malaria. Malaria Journal 7(1): 258.
31. Picard J, Mills A, Greenwood B (1992) The cost-effectiveness of chemoprophylaxis with Maloprim administered by primary health care workers in preventing death from malaria amongst rural Gambian children aged less than five years old. Trans R Soc Trop Med Hyg 86(6): 580-1.
32. Molyneux DH, Hotez PJ, Fenwick A, Newman RD, Greenwood B (2009) Neglected tropical diseases and the Global Fund. The Lancet 373(9660): 296-7.
33. Diallo D, Konate A, Dicko A (2009) 'A trial of IPTc in children sleeping under an ITN in Burkina Faso and Mali: Background and study design; Results from Burkina Faso; Results from Mali'. 5th MIM Pan African Malaria Conference Website: http://www.mimalaria.org/pamc/ConferenceInformation/ScientificProgram/SymposiumIPTCs/tabid/116/Default.aspx.
34. Nyonator FK, Awoonor-Williams JK, Phillips JF, Jones TC, Miller RA (2005) The Ghana Community-based Health Planning and Services Initiative for scaling up service delivery innovation. Health Policy and Planning 20(1): 25-34.
35. Nyonator FK, Badu Akosa A, Awoonor-Williams JK, Phillips JF, Jones TC (2008) Scaling Up Experimental Project Success with the Community-based Health Planning and Services Initiative in Ghana. In: Simmons R, Fajans P, Ghiron L, eds. Scaling Up Health Service Delivery: From Pilot Innovations to Policies and Programmes. Geneva: WHO.
36. Haines A, Sanders D, Lehmann U, Rowe AK, Lawn JE, et al. (2007) Achieving child survival goals: potential contribution of community health workers. The Lancet 369(9579): 2121-31.
37. Lewin S, Lavis JN, Oxman AD, Bastías G, Chopra M, et al. (2008) Supporting the delivery of cost-effective interventions in primary health-care systems in lowincome and middle-income countries: an overview of systematic reviews. The Lancet 372(9642): 928-39.
38. Tiono A, Kabore Y, Traore A, Convelbo N, Pagnoni F, al et (2008) Implementation of Home based management of malaria in children reduces the work load for peripheral health facilities in a rural district of Burkina Faso. Malaria Journal 7: 201.
39. Kidane G, Morrow RH (2000) Teaching mothers to provide home treatment of malaria in Tigray, Ethiopia: a randomised trial. The Lancet 356(9229): 550-5.
40. Pagnoni F, Kengeya-Kayondo J, Ridley R, Were W, Nafo-Traoré F, et al. (2005) Letter to the Editor: Artemisinin-based combination treatment in homebased management of malaria. Trop Med Int Health 10(6): 621-2.
41. Chinbuah AM, Gyapong JO, Pagnoni F, Wellington EK, Gyapong M (2006) Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6 months old in Ghana. Trop Med Int Health 11(7): 1003-16.
42. Ajayi I, Browne E, Bateganya F, Yar D, Happi C, et al. (2008) Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: A report from three study sites in sub-Saharan Africa. Malar J.7(1): 190.
43. Brooker S, Kabatereine NB, Fleming F, Devlin N (2008) Cost and costeffectiveness of nationwide school-based helminth control in Uganda: intracountry variation and effects of scaling-up. Health Policy Plan 23(1): 24-35.
44. Johns B, Torres TT (2005) Costs of scaling up health interventions: A Systematic Review. Health Policy and Planning 20(1): 1-13.
45. WHO CHOICE Webiste (2010) http://www.who.int/choice/en/.
46. James J, Aikins M, Binka F (2007) Malaria treatment in Northern Ghana: What is the treatment cost per case to households? African Journal of Health Sciences 14(1-2): 70-9.
47. Weinstein MC, Siegel JE, Garber AM, Lipscomb J, Luce BR, et al. (1997) Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Economics 6(5): 505-10.
48. Brouwer WBF, Koopmanschap MA, Rutten FFH (1997) Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Economics 6(5): 511-4.
49. Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L (1995) The friction cost method for measuring indirect costs of disease. Journal of Health Economics 14: 171-89.
50. Becker GS (1965) A theory of the allocation of time. Economic Journal 75: 493-517.
51. Morel C, Thang N, Xa N, Hung LX, Thuan LK, et al. (2008) The economic burden of malaria on the household in south-central Vietnam. Malaria Journal 7(1): 166.
52. Sicuri E, Davy C, Oa O, Ome M, Siba P, et al. (Submitted) The economic burden of malaria among young children on households in Papua New Guinea. Health Policy and Planning.
53. Alonzo Gonzalez M, Menendez C, Font F, Kahigwa E, Kimario J, et al. (2000) Cost-effectiveness of iron supplementation and malaria chemoprophylaxis in the prevention of anaemia and malaria among Tanzanian infants. Bull-World- Health-Organ; 78(1): 97-107.